Related references
Note: Only part of the references are listed.Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan
Ping Zhou et al.
BLOOD (2008)
Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis:: results of a phase II trial
Adam D. Cohen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating fcγ receptors
Jeffrey B. Stavenhagen et al.
CANCER RESEARCH (2007)
Monoclonal antibodies capable of discriminating the human inhibitory Fcγ-receptor IIB (CD32B) from the activating Fcγ-receptor IIA (CD32A):: biochemical, biological and functional characterization
Maria-Concetta Veri et al.
IMMUNOLOGY (2007)
The antiinflammatory activity of IgG: the intravenous IgG paradox
Falk Nimmerjahn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial
Vaishali Sanchorawala et al.
BLOOD (2007)
Antibodies, Fc receptors and cancer
Falk Nimmerjahn et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Fc gamma RIIb controls bone marrow plasma cell persistence and apoptosis
Zou Xiang et al.
NATURE IMMUNOLOGY (2007)
CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma
Christopher T. Rankin et al.
BLOOD (2006)
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
AM Boruchov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation
G Palladini et al.
BLOOD (2004)
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies
G Merlini et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Expression of functional activating and inhibitory Fc gamma receptors on human B cells
N Rabinovitch et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2004)
Expression of CD52 on plasma cells in plasma cell proliferative disorders
S Kumar et al.
BLOOD (2003)
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
HJ Lachmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
The tropism of organ involvement in primary systemic amyloidosis:: contributions of Ig VL germ line gene use and clonal plasma cell burden
RL Comenzo et al.
BLOOD (2001)
Share Paper
